Annual Drug Patent Expirations for VELTASSA
Veltassa is a drug marketed by Vifor Pharma and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug.
Drug patent litigation for VELTASSA.
This drug has one hundred and seventy-two patent family members in twenty-seven countries.
The generic ingredient in VELTASSA is patiromer sorbitex calcium. One supplier is listed for this compound. Additional details are available on the patiromer sorbitex calcium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
